Search & Filter

IR Information List

1807 items
Code Company Type Importance Title Date
4882 Perseus Proteomics Inc. Strategy Explanation Regarding Fundraising Nov 20, 2026
4443 Sansan, Inc. Strategy Presentation Materials on Making KiteRa a Group Company Nov 20, 2026
4444 INFONET GROUP inc. M&A Supplementary Explanation Materials for the Issuance of the 3rd and 4th Stock Acquisition Rights Nov 20, 2026
3988 SYS Holdings Co., Ltd. M&A Notice Regarding Acquisition of Shares (Becoming a Wholly-Owned Subsidiary) of Takahashi Giken Co., Ltd. Nov 20, 2026
9823 Mammy Mart Holdings Corporation Strategy Mid-Term Management Plan (2027–2029) — Balancing Further Differentiation and Profitability Improvement Nov 20, 2026
2334 eole Inc. Strategy Notice of Business Collaboration with SoftBank Corp. for Reciprocal Sales of AI Data Centers and GPU Computing Resources Nov 20, 2026
8977 Hankyu Hanshin REIT, Inc. Strategy Supplementary Explanatory Materials Regarding Asset Replacement and Press Release Nov 19, 2026
8960 United Urban Investment Corporation Strategy Notice Regarding Acquisition of Domestic Trust Beneficiary Interest (Midosuji Frontier) Nov 19, 2026
4918 Ivy Cosmetics Corporation Strategy Notification Regarding Grant of Patent Following National Phase Entry of International (PCT) Application for Anti-Cancer Substance (New Compound) on November 19, 2026 Nov 19, 2026
6417 Sankyo Co., Ltd. Strategy Notice Regarding Acquisition of Shares of the SUNTAC Group (Subsidiarization, etc.) Nov 19, 2026
4892 Cyfuse Biomedical K.K. Strategy Notice Regarding Progress in Development of New 3D Cellular Products and Recognition of Non-Operating Income Nov 19, 2026
3168 MERF Inc. Strategy Mid-Term Management Plan 2029 | Disclosure of Key Strategies and Financial Targets Nov 19, 2026
4596 Kubota Pharmaceutical Holdings Co., Ltd. Strategy Kubota Pharmaceutical Holdings Co., Ltd. Announcement of Start of Final Formulation Manufacturing of Emixstat Hydrochloride (Retakubo) by Consolidated Subsidiary Nov 19, 2026
9214 Recovery International Co.,Ltd. Strategy Notice Regarding Commencement of New Business Nov 18, 2026
8127 Yamato International Inc. M&A Notice of Acquisition of Shares of a Special Purpose Company (SPC) (Making Subsidiary, etc.) Nov 18, 2026
3750 ADR Biomedical Holdings Inc. Strategy Notice Regarding Commencement of a New Business Nov 18, 2026
3415 TOKYO BASE Co.,Ltd. Strategy Announcement: Accelerating Overseas Store Expansion — CONZ New York / PUBLIC TOKYO Seoul Opening in December Nov 18, 2026
8616 Tokai Tokyo Financial Holdings, Inc. Strategy Earnings / Investor Presentation Materials Nov 18, 2026
3083 Star seeds Co.,Ltd. M&A Notice of Execution of Basic Agreement on Business Alliance with Isuzu Co., Ltd. for Container-type AI Data Center Business Nov 18, 2026
4892 Cyfuse Biomedical K.K. Strategy Notice of Start of Investigator-Initiated Clinical Trial Based on Joint Research with Keio University and Fujita Health University — Development of a Novel Osteochondral Regeneration Platform Technology for Idiopathic Medial Femoral Condyle Osteonecrosis Nov 18, 2026